News
INMD
14.62
+1.04%
0.15
Weekly Report: what happened at INMD last week (1222-1226)?
Weekly Report · 55m ago
Weekly Report: what happened at INMD last week (1215-1219)?
Weekly Report · 12/22 10:09
InMode Price Target Cut to $15.00/Share From $16.00 by Canaccord Genuity
Dow Jones · 12/17 20:03
InMode Is Maintained at Hold by Canaccord Genuity
Dow Jones · 12/17 20:03
Canaccord Genuity Maintains Hold on InMode, Lowers Price Target to $15
Benzinga · 12/17 19:53
InMode price target lowered to $15 from $16 at Canaccord
TipRanks · 12/17 12:21
Weekly Report: what happened at INMD last week (1208-1212)?
Weekly Report · 12/15 10:16
InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In
Seeking Alpha · 12/11 23:26
Weekly Report: what happened at INMD last week (1201-1205)?
Weekly Report · 12/08 10:14
Weekly Report: what happened at INMD last week (1124-1128)?
Weekly Report · 12/01 10:10
Weekly Report: what happened at INMD last week (1117-1121)?
Weekly Report · 11/24 10:15
Noteworthy ETF Inflows: AVDV, CSTM, MRX, INMD
NASDAQ · 11/17 15:47
Weekly Report: what happened at INMD last week (1110-1114)?
Weekly Report · 11/17 10:15
There Might Be More To InMode's (NASDAQ:INMD) Story Than Just Weak Earnings
Simply Wall St · 11/12 18:54
Weekly Report: what happened at INMD last week (1103-1107)?
Weekly Report · 11/10 10:12
How Softer Q3 Results and Leadership Changes at InMode (INMD) Have Changed Its Investment Story
Simply Wall St · 11/07 17:57
Barclays Remains a Buy on InMode (INMD)
TipRanks · 11/07 09:37
InMode Price Target Cut to $16.00/Share From $16.25 by UBS
Dow Jones · 11/06 18:52
InMode Is Maintained at Neutral by UBS
Dow Jones · 11/06 18:52
UBS Maintains Neutral on InMode, Lowers Price Target to $16
Benzinga · 11/06 18:45
More
Webull provides a variety of real-time INMD stock news. You can receive the latest news about Inmode Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About INMD
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.